Diet, herbs, and nutritional protection against oxidative stress in neurological diseases

Oxidative Stress and Neurodegenerative Disorders

Volumn , Issue , 2007, Pages 525-541

  Kusano Bucalen Ferrari, Carlos ^a  

^a Postgraduate Program of Functional Nutrition and Quality of Life   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880931216     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452809-4/50164-2     Document Type: Chapter

References (122)

1. BN Ames, MK Shigenaga and TM Hagen (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci. 90 7915-7922.
2. B Halliwell and S Chirico (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 57 715-725. (suppl.)
3. TH Zastawny, M Dabrowska, T Jaskolski, M Klimarczyk, L Kulinski, A Koszela, M Szczesniewicz, M Sliwinska, P Witkowski and R Olinski (1998) Comparison of oxidative base damage in mitochondrial and nuclear DNA. Free Rad Biol Med. 24 722-725.
4. DA Cottrell, EL Blakely, GM Borthwick, MA Johnson, GA Taylor, EJ Brierley, PG Ince and DM Turnbull (2000) Role of mitochondrial DNA mutations in disease and aging. Ann NY Acad Sci. 908 199-220.
5. CKB Ferrari (2001) Oxidative stress pathophysiology: searching for an effective antioxidant protection. Int Med J. 8 175-184.
6. AG Estevez, JP Crow, JB Sampson, C Reiter, Y Zhuang, GJ Richardson, MM Tarpey, L Barbeito and JS Beckman (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286 2498-2500.
7. JE Kokoszka, P Coskun, LA Esposito and DC Wallace (2001) Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptos. Proc Natl Acad Sci USA 98 2278-2283.
8. M Merad-Boudia, A Nicole, D Santiard-Baron, C Saillé and I Ceballos-Picot (1998) Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem Pharmacol. 56 645-655.
9. MN Patel (2002) Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Rad Res. 36 1139-1146.
10. SM Cardoso, C Pereira and CR Oliveira (1999) Mitochondrial function is differentially affected upon oxidative stress. Free Rad Biol Med. 26 3-13.
11. RT Matthews, L Yang, S Browne, M Baik and F Beal (1998) Coenzyme Q10 administration increases brain mito- chondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95 8892-8897.
12. GF Kelso, CM Porteous, CV Coulter, G Hughes, WK Porteous, EC Ledgerwood, RAJ Smith and MP Murphy (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells. J Biol Chem. 276 4588-4596.
13. GG Duthie (1993) Lipid peroxidation. Eur J Clin Nutr. 47 759-764.
14. TM Hagen, RT Ingersoll, CM Wehr, J Lykkesfeldt, V Vinarsky, JC Bartholomew, MH Song and BN Ames (1998) Acetyl-L-carnitine fed to old rats partially restored mitochondrial function and ambulatory activity. Proc Natl Acad Sci USA 95 9562-9566.
15. ZK Binienda (2001) Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. Ann NY Acad Sci. 993 289-295.
16. A Virmani, F Gaetani, S Imam, Z Binienda and S Ali (2003) Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann NY Acad Sci. 993 197-207.
17. DJ Mahoney, G Parise and MA Tarnopolsky (2002) Nutritional and exercise-based therapies in the treatment of mitochondrial disease. Curr Opin Clin Nutr Metb Care. 5 619-629.
18. CKB Ferrari (2000) Free radicals, lipid peroxidation and antioxidants in apoptosis: implications in cancer, cardiovascular and neurological diseases. Biologia 55 581-590.
19. CKB Ferrari (2000) Apoptose: Importância da maquinaria de morte celular no controle e na patogênese das doenças. Rev Cienc Med. 9 21-31.
20. KA Youdim and JA Joseph (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Rad Biol Med. 30 583-594.
21. CKB Ferrari (2004) Functional foods, herbs, and nutraceuticals: Towards biochemical mechanisms of healthy aging. Biogerontology 5 275-289.
22. MA Smith, CA Rottkamp, A Nunomura, AK Raina and G Perry (2000) Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502 139-144.
23. U Padhye (2003) Excess dietary iron is the root cause for increase in childhood autism and allergies. Med Hypot. 61 220-222.
24. KJ Barnham, CL Masters and AI Bush (2003) Neurodegenerative diseases and oxidative stress. Nature Rev Drug Disc. 3 205-214.
25. X Chen and DU Ahn (1998) Antioxidant activities of six natural phenolics against lipid oxidation induced by Fe2+ or ultraviolet light. J Am Oil Chem Soc. 75 1717-1721.
26. GKB Lopes, HM Shulman and M Hermes-Lima (1999) Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. Biochim Biophys Acta/GS. 1472 142-152.
27. L Mira, MT Fernandez, M Santos, R Rocha, MH Florêncio and KR Jennings (2002) Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Rad Res. 36 1199-1208.
28. H Atamna, DW Killilea, AN Killilea and BN Ames (2002) Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci. 99 14807-14812.
29. JE Morley (2004) The top 10 hot topics in aging. J Gerontol. 59 24-33.
30. JS Leinonen, J-K Ahonen, K Lönnrot, M Jehkonen and P Dastidar (2004) Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 31 33-39.
31. SE Gariballa, TP Hutchin and AJ Sinclair (2002) Antioxidant capacity after ischemic stroke. QJM. 95 685-690.
32. G Block, AR Mangels, EP Norkus, BH Patterson, OA Levander and PR Taylor (2001) Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 37 261-267.
33. KJ Joshipura, A Ascherio, JE Manson, MJ Stampfer, EB Rimm, FE Speizer, CH Hennekens, D Spiegelman and WC Willett (1999) Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282 1233-1239.
34. M Endres, Z-Q Wang, S Namura, C Waeber and MA Moskowitz (1997) Ischemic brain injury is mediated by the activation of poly (ADP)-ribose polymerase. J Cerebr Blood Flow Metab. 17 1143-1151.
35. SK Mukherjee and J.J.D. Adams Jr.JD..jr. (1997) The effects of aging and neurodegeneration on apoptosis-associated DNA fragmentation and the benefits of nicotinamide. Mol Chem Pathol. 32 59-74.
36. F Sadanaga-Akiyoshi, H Yao, S-I Tanuma, T Nakahara, JS Hong, S Ibayashi, H Uchimura and M Fujishima (2003) Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumb. Neurochem Res. 28 1227-1234.
37. L Klaidman, M Morales, S Kem, J Yang, ML Chang and J.J.D. Adams Jr.JD..jr. (2003) Nicotinamide offers multiple pro- tective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial fu. Pharmacology 69 150-157.
38. KL Brewer and JS Hardin (2004) Neuroprotective effects of nicotinamide after experimental spinal cord injury. Acad Emerg Med. 11 125-130.
39. J Yang, LK Klaidman, ML Chang, S Kem, T Sugawara, P Chan and JD Adams (2002) Nicotimamide therapy pro- tects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav. 73 901-910.
40. T Yamaguchi, K Sano, K Takakura, I Saito, Y Shinohara, T Asano and H Yasuhara (1998) Ebselen in acute ischemic stroke. A placebo-controlled, double-blind clinical trial. Stroke 29 12-17.
41. S Namura, I Nagata, S Takami, H Masayasu and H Kikuchi (2001) Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 32 1906-1911.
42. M Thiyagarajan and SS Sharma (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74 969-985.
43. S Liu, JE Manson, MJ Stampfer, KM Rexrode, FB Hu, EB Rimm and WC Willett (2000) Whole grain consumption and risk of ischemic stroke in women. JAMA 284 1534-1540.
44. NM McKeown and P Jacques (2001) Whole grain intake and risk of ischemic stroke in women. Nutr Rev. 59 149-152.
45. SO Keli, MG Hertog, EJ Feskens and D Kromhout (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Int Med. 156 637-642.
46. T Hirvonen, J Virtamo, P Korhonen, D Albanes and P Pietinen (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31 2301-2306.
47. JE Freedman, C Parker, L Li, JA Perlman, B Frei, V Ivanov, LR Deak, MD Iafrati and JD Folts (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103 2792-2798.
48. AE Hak, J Ma, CB Powell, H Campos, JM Gaziano, WC Willett and MJ Stampfer (2004) Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 35 1584-1588.
49. K He, A Merchant, EB Rimm, BA Rosner, MJ Stampfer, WC Willett and A Ascherio (2004) Folate, Vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35 169-174.
50. WK Al-Delaimy, KM Rexrode, FB Hu, CM Albert, MJ Stampfer, WC Willett and JE Manson (2004) Folate intake and risk of incident stroke among women. Stroke 35 1259-1263.
51. LA Bazzano, J He, LG Ogden, C Loria, S Vupputuri, L Myers and PK Whelton (2002) Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study.National Health and Nutrition Examination Survey. Stroke 33 1183-1188.
52. B Van Guelpen, J Hultdin, I Johansson, B Stegmayr, G Hallmans, TK Nilsson, L Weinehall, C Witthöft, R Palmqvist and A Winkvist (2005) Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke. Stroke 36 1426-1431.
53. R Ullegaddi, HJ Powers and SE Gariballa (2005) Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr. 59 1367-1373.
54. A Ascherio, EB Rimm, MA Hernan, E Giovanucchi, I Kawachi, MJ Stampfer and WC Willett (1999) Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Int Med. 130 963-970.
55. LA Yochum, AR Folsom and LH Kushi (2000) Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 72 476-483.
56. JM Leppälä, J Virtamo, R Fogelholm, D Albanes, PR Taylor and OP Heinonen (2000) Vitamin E and beta-carotene supplementation in high risk for stroke. A subgroup analysis of the Alfa-tocopherol, beta-carotene cancer prevention study. Arch Neurol. 57 1503-1509.
57. H Bosma, B.M.P.J. van Boxtel MPJ, RWHM Ponds, M Jelicic, P Houx, J Metsemakers and J Jolles (2002) Engaged lifestyle and cognitive function in middle and old-aged, non-demented persons: a reciprocal association? Zeitschr Gerontol Geriatr. 35 575-581.
58. J Liu, E Head, AM Gharib, W Yuan, RT Ingersoll, TM Hagen, CW Cotman and BN Ames (2002) Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversed by feeding acetyl-L-carnitine and/or R-α-lipoic. Proc Natl Acad Sci. 99 2356-2361.
59. RM Ortega, AM Requejo, AM López-Sobaler, P Andrés, B Navia, JM Perea and F Robles (2002) Cognitive function in elderly people is influenced by vitamin E status. J Nutr. 132 2065-2068.
60. AJ Perkins, HC Hendrie, CM Callahan, S Gao, FW Unverzagt, Y Xu, KS Hall and SL Hui (1999) Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 150 37-44.
61. C Berr (2000) Cognitive impairment and oxidative stress in the elderly: Results of epidemiological studies. BioFactors 13 205-209.
62. WJ Perrig, P Perrig and HB Stahelin (1997) The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 45 718-724.
63. J Terao and MK Piskula (1999) Flavonoids and membrane lipid peroxidation inhibition. Nutrition 15 790-791.
64. KM Brown, PC Morrice and GG Duthie (1998) Erythrocyte membrane fatty acid composition of smokers and non- smokers: effects of vitamin E supplementation. Eur J Clin Nutr. 52 145-150.
65. EB Monroe, JC Jurchen, J Lee, SS Rubakhin and JV Sweedler (2005) Vitamin E imaging and localization in the neuronal membrane. J Am Chem Soc. 127 12152-12153.
66. A Saija, M Scalese, M Lanza, D Marzullo, F Bonina and F Castelli (1995) Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Rad Biol Med. 19 481-486.
67. CKB Ferrari (2005) Bioquímica dos alimentos funcionais, nutrição e saúde. Nutr Profis. 1 21-28.
68. TD Heijer, LJ Launer, G.J.C. de Groot JC, L.F.-E. de Leeuw F-E, M Oudkerk, G.J. van Gijn J, A Hofman and MMB Breteler (2001) Serum carotenoids and cerebral white matter lesions: The Rotterdam Scan Study. J Am Geriatr Soc. 49 642-646.
69. MJ Engelhart, MI Geerlings, A Ruitenberg, S.J.C. van Swieten JC, A Hofman, JC Witteman and MM Breteler (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 3223-3229.
70. CJ Bates, D Benton, HK Biesalski, HB Staehelin, S.W. van Staveren W, P Stehle, PM Suter and G Wolfram (2002) Nutrition and aging: a consensus statement. J Nutr Health Aging 6 103-116.
71. D Erba, P Riso, A Colombo and G Testolin (1999) Supplementation of Jurkat T cells with green tea extract decreases oxidative damage due to iron. J Nutr. 129 2130-2134.
72. B Moosmann and C Behl (1999) The antioxidant neuroprotective effects of estrogens and phenolic com- pounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96 8867-8872.
73. H Suganuma, S Kaburagi, T Inakuma and Y Ishiguro (2002) Ameliorative effect of dietary ingestion of lycopene and tomato rich in lycopene on learning impairment in senescence-accelerated mice (SAMP8). Food Sci Technol Res. 8 183-187.
74. J Louis-Sylvestre (1999) Phosphatidylsérine et troubles mnésiques du sujet âge. Cah Nutr Diét. 34 349-357.
75. M-C Hung, K Shibasaki, R Yoshida, M Sato and K Imaizumi (2001) Learning behaviour and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: influence of a phosphatidylcholine di. Brit J Nutr. 86 163-171.
76. BN Ames (1999) Micronutrient deficiencies. A major cause of DNA damage. Ann NY Acad Sci. 889 87-106.
77. U Keil, A Bonert, CA Marques, I Scherping, J Weyermann, JB Strosznajder, F Muller-Spahn, C Haass, C Czech, L Pradier, WE Muller and A Eckert (2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem. 279 50310-50320.
78. MA Smith, GJ Petot and G Perry (1999) Diet and oxidative stress: a novel synthesis of epidemiological data no Alzheimer's disease. J Alzheim Dis. 1 203-206.
79. S Larrieu, L Letenneur, C Helmer, JF Dartigues and P Barberger-Gateau (2004) Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging 8(3), 150-154.
80. J Gusman, H Malonne and G Atassi (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22 1111-1117.
81. P Durand, M Prost, N Loreau, S Lussier-Cacan and D Blache (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest. 81 645-672.
82. S Seshadri, A Beiser, J Selhub, PF Jacques, IH Rosenberg, RB D'Agostino, PWS Wilson and PA Wolf (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med. 346 476-483.
83. P Quadri, C Fragiacomo, R Pezzati, E Zanda, G Forloni, M Tettamanti and U Lucca (2004) Homocysteine, folate, and vitamin B12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 80 114-122.
84. WMR Broekmans, IAA Klöpping-Ketelaars, CRWC Schuurman, H Verhagen, B.H. van der Berg H, FJ Kok and P.G. van Poppel G (2000) Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutr. 130 1578-1583.
85. F Nappo, R.N. De Rosa N, R Marfella, L.D. De Lucia D, D Ingrosso, AF Perna, B Farzati and D Giugliano (1999) Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 281 2113-2118.
86. PP Zandi, JC Anthony, AS Khachaturian, SV Stone, D Gustafson, JT Tschanz, MC Norton, B.K.A. Welsh- Bohmer KA and JCS Breitner (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements. Arch Neurol. 61 82-88.
87. MC Morris, DA Evans, JL Bienias, PA Scherr, CC Tangney, LE Hebert, DA Bennett, RS Wilson and N Aggarwal (2004) Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatr. 75 1093-1099.
88. MC Morris, DA Evans, JL Bienias, CC Tangney, DA Bennett, RS Wilson, N Aggarwal and J Schneider (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 60 940-946.
89. D Laurin, KH Masaki, DJ Foley, LR White and LJ Launer (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol. 159 959-967.
90. RY Yuan, M-Y Wu and S-P Hu (2000) Antioxidant status in patients with Parkinson's disease. Nutr Res. 20 647-652.
91. SM Zhang, MA Hernán, H Chen, D Spiegelman, WC Willett and A Ascherio (2002) Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 59 1161-1169.
92. KS Zafar, A Siddiqui, I Sayeed, M Ahmad, S Salim and F Islam (2003) Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem. 84 438-446.
93. K Yaffe, TE Clemons, WL McBee and AS Lindblad (2004) Impact of antioxidants, zinc, and copper on cognition in the elderly. Neurology 63 1705-1707.
94. S Bastianetto, W-H Zheng and R Quirion (2000) The Ginkgo biloba extract (Egb 761) protects and rescues hippocam- pal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents. J Neurochem. 74 2268-2277.
95. A Louajri, S Harraga, V Godot, G Toubin, JP Kantelip and P Magnin (2001) The effect of Ginkgo Biloba extract on free radical production in hypoxic rats. Biol Pharm Bull. 24 710-712.
96. S Bastianetto, C Ramassamy, S Doré, Y Christen, J Poirier and R Quirion (2000) The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid. Eur J Neurosci. 12 1882-1890.
97. CMH Watanabe, S Wolffram, P Ader, G Rimbach, L Packer, JJ Maguire, PG Schultz and K Gohil (2001) The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 98 6577-6800.
98. H Wagner (1999) Phytomedicine research in Germany. Environm Health Perspect. 107 779-781.
99. E Ernst (2002) The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Worth, Ginseng, Echinacea, Saw Palmeto, and Kava. Ann Intern Med. 136 42-53.
100. D.M. van Dongen M, R.E. van Rossum E, A Kessels, H Sielhorst and P Knipchild (2003) Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol. 56 367-376.
101. G.A. Das Gupta A (2003) Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol. 120 127-137.
102. SY Nah and EW McCleskey (1994) Ginseng root extract inhibits calcium channels in rat sensory neurons through a similar path, but different receptor, as mu-type opioids. J Ethnopharmacol. 42 45-51.
103. YH Kim, KH Park and HM Rho (1996) Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem. 271 24539-24543.
104. X Chen, S Salwinski and TJ Lee (1997) Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelation via a nitric oxide pathway. Clin Exp Pharmacol Physiol. 24 958-959.
105. E Couture (2002) Le ginseng. Québec Pharm. 49 106-108.
106. X-C Chen, Y-C Zhou, Y Chen, Y-G Zhu, F Fang and L-M Chen (2005) Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin. 26 56-62.
107. GB Mahady, C Gyllenhaal, HHS Fong and NR Farnsworth (2000) Ginsengs: a review of safety and efficacy. Nutr Clin Care 3 90-101.
108. AY Sun, A Simonyi and GY Sun (2002) The “French paradox” and beyond: neuroprotective effects of polyphenols. Free Rad Biol Med. 32 314-318.
109. RL Galli, B Shukitt-Hale, KA Youdim and JA Joseph (2002) Fruit polyphenolics and brain aging. Nutritional interventions targeting age-related neuronal and behavioral deficits. Ann NY Acad Sci. 959 128-132.
110. E Skrzydlewska, J Ostrowska, R Farbiszewski and K Michalak (2002) Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 9 232-238.
111. EJ Rogers, S Milhalik, D Orthiz and TB Shea (2004) Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J Nutr Health Aging 8 92-97.
112. R Wattiaux, K Jaworski and S Wattiaux-de-Coninck (2000) Effects du vin sur les membranes cellulaires et endocellulaires “in vitro. J Intern Sci Vigne Vin. 34 177-180.
113. C.J.P. De la Cruz JP, L Quintero, MA Villalobos and C.F. Sanchez de la Cuesta F (2000) Lipid peroxidation and glutathione sytem in hyperlipemic rabbits: influence of olive oil administration. Biochim Biophys Acta 1485 36-44.
114. V Solfrizzi, F Panza, F Torres, F Mastroianni, P.A. Del Parigi A, A Venezia and A Capurso (1999) High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 52 1563-1569.
115. F Perez-Jimenez (2005) International conference on the healthy effect of virgin olive oil. Eur J Clin Invest. 35 421-424.
116. T Moriguchi, RS Greiner and J.N. Salem Jr.N..jr. (2000) Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 75 2563-2573.
117. G Champeil-Potokar, I Denis, B Goustard-Langelier, JM Alessandri, P Guesnet and M Lavialle (2004) Astrocytes in culture require docosahexanoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids. J Neurosci Res. 75 96-106.
118. M Hashimoto, S Hossain, T Shimada, K Sugioka, H Yamasaki, Y Fujii, O.J. IshibashiY Oka J and O Shido (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 81 1084-1091.
119. H Iso, KM Rexrode, MJ Stampfer, JA Manson, GA Colditz, FE Speizer, CH Hennekens and WC Willett (2001) Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285 304-312.
120. J Clarke, G Herzberg, J Peeling, R Buist and D Corbett (2005) Dietary supplementation of omega-3 polyunsaturated fatty acids worsens forelimb motor function after intracerebral hemorrhage in rats. Exp Neurol. 191 119-127.
121. MI Castro-González, A Ojeda, JL Silencio, L Cassis, H Ledesma and F Pérez-Gil (2004) Perfil lipídico de 25 pescados marinos mexicanos con especial énfasis en sus ácidos grasos n-3 como componentes nutracéuticos. Arch Latinoam Nutr. 54 328-336.
122. A Trichopoulou and E Vassilopoulou (2000) Mediterranean diet and longevity. Brit J Nutr. 84(Suppl. 2), S205-S209.